ArticleFrontiers in pharmacology2025

Pharmacokinetics, safety and tolerability of ipatasertib in combination with palbociclib and fulvestrant in patients with advanced breast cancer in a phase Ib study.

Kit Wun Kathy Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.